← FDA Drug Approvals (Drugs@FDA)

EXEMESTANE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: UPSHER SMITH LABS · Approved 2017-07-26

Drug application

FDA Application #

ANDA209208

Application type

Abbreviated New Drug Application (Generic)

Brand name

EXEMESTANE

Generic name

EXEMESTANE

Active ingredients

EXEMESTANE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

UPSHER SMITH LABS

Manufacturer

Upsher-Smith Laboratories, Inc.

First approval

2017-07-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown